MEDICIS PHARMACEUTICAL CORP
CIK 0000859368
Revenue (TTM)
$763.16M
+3.6% YoY
Q3 Sep 2012
Net Income (TTM)
$40.66M
+203.0% YoY
Q3 Sep 2012
EPS Diluted (TTM)
$0.64
+200.0% YoY
Q3 Sep 2012
Gross Margin
89.6%
Q3 Sep 2012
Operating Margin
11.9%
Q3 Sep 2012
Net Margin
5.3%
Q3 Sep 2012
Free Cash Flow (TTM)
$165.95M
Q3 Sep 2012
Cash
$130.12M
Q3 Sep 2012
Total Debt
—
Q3 Sep 2012
Shares Outstanding
—
Q3 Sep 2012